Gastroesophageal reflux disease (GERD) is a prevalent problem in patients with interstitial lung disease (ILD) before or after lung transplantation. It has been linked to the pathogenesis of ILD, but the precise nature of this relationship remains unclear. Antireflux surgery has shown benefit in slowing progression of ILD in retrospective studies; however, the only randomized study was underpowered to detect a statistical difference. Lung transplantation further worsens the rates of GERD and other gastrointestinal issues by multiple mechanisms. After lung transplant, many retrospective studies show that antireflux surgery is associated with lower rates of chronic allograft dysfunction and better overall survival.
HershcoviciTJhaLKJohnsonT, et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(11-12):1295-1305. Accessed December 15, 2024. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2036.2011.04870.x
2.
StovoldRForrestIACorrisPA, et al. Pepsin, a biomarker of gastric aspiration in lung allografts. Am J Respir Crit Care Med. 2012;175(12):1298-1303. doi:101164/rccm200610-1485OC
3.
MurthySCNowickiERMasonDP, et al. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg. 2011;142(1):47-52.e3.
YusenRDEdwardsLBDipchandAI, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report—2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1170-1184. Accessed November 17, 2024. http://www.jhltonline.org/article/S1053249816303096/fulltext
6.
VerledenGMGlanvilleARLeaseED, et al. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment―a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant. 2019;38(5):493-503.
7.
VerledenGMRaghuGMeyerKCGlanvilleARCorrisP.A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant. 2014;33(2):127-133.
8.
SatoMWaddellTKWagnetzU, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30(7):735-742. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/21419659/
9.
KroshusTJKshettryVRSavikKJohnRHertzMIBolmanRM.Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg. 1997;114(2):195-202.
10.
GirgisRETuIBerryGJ, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996;15(12):1200-1208. Accessed November 17, 2024. https://europepmc.org/article/med/8981205
11.
MasudaTMittalSKKovacsB, et al. Thoracoabdominal pressure gradient and gastroesophageal reflux: insights from lung transplant candidates. Dis Esophag. 2018;31(10):1-25. doi:10.1093/dote/doy025
12.
TobinRWPopeCEPellegriniCAEmondMJSilleryJRaghuG.Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012;158(6):1804-1808. doi:101164/ajrccm15869804105. Accessed March 3, 2025. www.atsjournals.org
13.
SweetMPPattiMGLeardLE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg. 2007;133(4):1078-1084.
14.
RaghuGFreudenbergerTDYangS, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27(1):136-142. Accessed March 3, 2025. https://publications.ersnet.org/content/erj/27/1/136
15.
SavarinoECarboneRMarabottoE, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013;42(5):1322-1331. Accessed March 11, 2025. https://publications.ersnet.org/content/erj/42/5/1322
16.
Bédard MéthotDLeblancÉLacasseY. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest. 2019;155(1):33-43.
17.
IoannidisJPAVlachoyiannopoulosPGHaidichAB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118(1):2-10.
18.
DenisPDucrottePPasquisPLefrancoisR.Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration. 1981;42(1):21-24.. doi:10.1159/000194399
LockG.Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol. 1998;93(3):341-345.
21.
MarieIDominiqueSPLevesqueH, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Care Res. 2001;45(4):346-354. Accessed April 1, 2025. https://onlinelibrary.wiley.com/doi/10.1002/1529-0131
22.
PellegriniCADeMeesterTRJohnsonLFSkinnerDB.Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. Surgery. 1979;86(1):110-119. Accessed March 3, 2025. https://www.surgjournal.com/action/showFullText?pii=0039606079901375
23.
CiovicaRGadenstätterMKlinglerANeumayerCSchwabGP.Laparoscopic antireflux surgery provides excellent results and quality of life in gastroesophageal reflux disease patients with respiratory symptoms. J Gastrointest Surg. 2005;9(5):633-637.
24.
PattiMGArceritoMTamburiniA, et al. Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms. J Gastrointest Surg. 2000;4(2):143-149.
25.
LindenPAGilbertRJYeapBY, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131(2):438-446. Accessed March 3, 2025. https://pubmed.ncbi.nlm.nih.gov/16434276/
26.
RaghuGMorrowECollinsBF, et al. Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre. Eur Respir J. 2016;48(3):826-832. Accessed March 3, 2025. https://publications.ersnet.org/content/erj/48/3/826
27.
RaghuGPellegriniCAYowE, et al. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. Lancet Respir Med. 2018;6(9):707-714. Accessed March 3, 2025. https://pubmed.ncbi.nlm.nih.gov/30100404/
28.
TamburiniNAndolfiCFisichellaPM.A narrative review of minimally invasive fundoplication for gastroesophageal reflux disease and interstitial lung disease. Ann Esophag. 2022;5:6096. Accessed March 3, 2025. https://aoe.amegroups.org/article/view/6096/html
29.
PoirierNCTailleferRTopartPDuranceauA.Antireflux operations in patients with scleroderma. Ann Thorac Surg. 1994;58(1):66-73.
MansourKAMaloneCE.Surgery for scleroderma of the esophagus: a 12-year experience. Ann Thorac Surg. 1988;46(5):513-514.
32.
YanJStrongATSharmaG, et al. Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis. Surg Endosc. 2018;32(9):3855-3860. Accessed March 5, 2025. https://link.springer.com/article/10.1007/s00464-018-6115-2
33.
MasudaTMittalSKKovácsB, et al. Foregut function before and after lung transplant. J Thorac Cardiovasc Surg. 2019;158(2):619-629.
34.
PosnerSFinnRTShimpiRA, et al. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophag. 2019;32(10):1-8. doi:10.1093/dote/doz039
HervePSilbertDCerrinaJSimonneauGDartevelleP.Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. Chest. 1993;103(1):59-63.
37.
HigenbottamTJacksonMWoolmanPLowryRWallworkJ.The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis. 2012;140(1):58-61. doi:101164/ajrccm/140158
38.
LucanVCBerardinelliL.Gastrointestinal side effects of post-transplant therapy. J Gastrointestin Liver Dis. 2016;25(3):367-373. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/27689202/
39.
BerkowitzNSchulmanLLMcGregorCMarkowitzD.Gastroparesis after lung transplantation: potential role in postoperative respiratory complications. Chest. 1995;108(6):1602-1607.
40.
MertensVBlondeauKVanaudenaerdeB, et al. Gastric juice from patients “on” acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells. J Clin Gastroenterol. 2010;44(10):e230-e235. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/20216077/
41.
HadjiliadisDDavisRDSteeleMP, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17(4):363-368. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/12868994/
42.
LoWKBurakoffRGoldbergHJFeldmanNChanWW.Pre-transplant impedance measures of reflux are associated with early allograft injury after lung transplantation. J Heart Lung Transplant. 2015;34(1):26-35. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/25444368/
43.
LoWKGoldbergHJBurakoffRFeldmanNChanWW.Increased proximal acid reflux is associated with early readmission following lung transplantation. Neurogastroenterol Motil. 2016;28(2):251-259. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/26568193/
44.
CantuEAppelJZHartwigMG, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78(4):1142-1151.
45.
HartwigMGAndersonDJOnaitisMW, et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg. 2011;92(2):462-469.
46.
KennedyVEToddJLPalmerSM.Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome. Am J Transplant. 2013;13(3):552-561.
47.
LevyLAhmedMHusztiE, et al. Bronchoalveolar bile acids are associated with acute rejection, inflammation, and allograft survival: a multi-center study. J Heart Lung Transplant. 2021;40(4):S62-S63.
48.
UrsoALeiva-JuárezMMBrigantiDF, et al. Aspiration of conjugated bile acids predicts adverse lung transplant outcomes and correlates with airway lipid and cytokine dysregulation. J Heart Lung Transplant. 2021;40(9):998-1008.
49.
ZhangCYKAhmedMHusztiE, et al. Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration. J Heart Lung Transplant. 2020;39(9):934-944.
50.
KilicAShahASMerloCAGourinCGLidorAO.Early outcomes of antireflux surgery for United States lung transplant recipients. Surg Endosc. 2013;27(5):1754-1760. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/23271270/
51.
RaziaDMittalSKWaliaR, et al. Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable. Surg Endosc. 2023;37(2):1114-1122. Accessed March 10, 2025. https://link.springer.com/article/10.1007/s00464-022-09598-9
52.
KrahelskiOAliINamgoongC, et al. Interventional anti-reflux management for gastro-oesophageal reflux disease in lung transplant recipients: a systematic review and meta-analysis. Surg Endosc. 2024;39(1):19-38. Accessed March 3, 2025. https://link.springer.com/article/10.1007/s00464-024-11392-8
53.
DavisRDLauCLEubanksS, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125(3):533-542.
54.
Abbassi-GhadiNKumarSCheungB, et al. Anti-reflux surgery for lung transplant recipients in the presence of impedance-detected duodenogastroesophageal reflux and bronchiolitis obliterans syndrome: a study of efficacy and safety. J Heart Lung Transplant. 2013;32(6):588-595. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/23540400/
55.
RobertsonAGNKrishnanAWardC, et al. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J. 2012;39(3):691-697. Accessed March 10, 2025. https://publications.ersnet.org/content/erj/39/3/691
56.
Leiva-JuarezMMBenvenutoLCostaJ, et al. Identification of lung transplant recipients with a survival benefit after fundoplication. Ann Thorac Surg. 2022;113(6):1801-1810. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/34280376/
57.
GreenCLGulackBCKeshavjeeS, et al. Reflux surgery in lung transplantation: a multicenter retrospective study. Ann Thorac Surg. 2023;115(4):1024-1032.
58.
RaziaDMittalSKFournierS, et al. Antireflux surgery versus medical management of gastro-oesophageal reflux after lung transplantation. Eur J Cardio-Thor Surg. 2023;63(3):63. doi:10.1093/ejcts/ezad063
59.
Biswas RoySElnahasSSerroneR, et al. Early fundoplication is associated with slower decline in lung function after lung transplantation in patients with gastroesophageal reflux disease. J Thorac Cardiovasc Surg. 2018;155(6):2762-2771.e1. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/29572022/
60.
KhorYHBissellBGhazipuraM, et al. Antacid medication and antireflux surgery in patients with idiopathic pulmonary fibrosis a systematic review and meta-analysis. Ann Am Thorac Soc. 2022;19(5):833-844. Accessed March 3, 2025. www.atsjournals.org
61.
LoWKGoldbergHJWeeJFisichellaPMChanWW.Both pre-transplant and early post-transplant antireflux surgery prevent development of early allograft injury after lung transplantation. J Gastrointest Surg. 2016;20(1):111-118. Accessed March 10, 2025. https://pubmed.ncbi.nlm.nih.gov/26493975/
